Article
Temozolomide induces senescence but not apoptosis in human melanoma cells
30 Oct 2007
Abstract excerpt
Temozolomide (TMZ), a DNA alkylating agent used in the treatment of melanoma, is believed to mediate its effect by addition of a methyl group to the O(6) position of guanine in DNA. Resistance to the agent may be in part due to the activity of O(6)-methylguanine-DNA methyl transferase (MGMT). In the present study, we show that sensitivity of melanoma cells to TMZ was dependent on their p53 status and levels of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
